Opportunistic fungal infection in children and management

Area of Science:

• Mycology
• Pediatric Infectious Diseases
• Immunocompromised Host

Background:

• Opportunistic mycoses are fungal infections caused by low-pathogenicity agents, primarily affecting immunocompromised individuals.
• Advances in transplantation, preterm care, immunosuppressive therapies, and intensive care have led to an increase in vulnerable pediatric patients.
• The use of biologic agents in pediatric diseases creates a new at-risk population for opportunistic fungal infections.

Purpose of the Study:

• To review the cutaneous manifestations of opportunistic fungal infections in pediatric patients.
• To highlight the importance of clinical suspicion for deep fungal infections in immunocompromised children.
• To discuss infections caused by Aspergillus, Blastomyces, Histoplasma, and Mucormycosis.

Main Methods:

• Literature review focusing on cutaneous manifestations of specific opportunistic fungal infections.
• Analysis of recent case reports illustrating the presentation of fungal infections in immunocompromised pediatric patients.
• Synthesis of current understanding regarding identification and treatment strategies.

Main Results:

• Cutaneous infections, such as histioplasmosis and blastomycosis, can be the initial presenting sign of underlying immunodeficiency.
• Immunosuppressed pediatric patients are increasingly susceptible to infections by fungi like Aspergillus, Blastomyces, Histoplasma, and Mucormycosis.
• High clinical suspicion is necessary for diagnosing deep fungal infections in this population.

Conclusions:

• Cutaneous manifestations are significant indicators of opportunistic mycoses in immunocompromised children.
• Enhanced understanding and research into the identification and treatment of these fungal diseases are critical.
• Improved diagnostic and therapeutic approaches can significantly enhance patient care and outcomes.